COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center

Pioneer III

Purpose of Study

Demonstrate the safety and efficacy of the Buma DES in patients with significant ischemia requiring percutaneous coronary intervention (PCI) with implantation of drug eluting stents for the treatment of stable coronary artery disease or acute coronary syndromes

Trial Status

In follow up

Eligibility Criteria

20 years or older, symptomatic ischemic heart disease, or acute coronary syndromes that require elective or urgent PCI

Duration of Participation

Approximately 5 years

Contact Name: Ketra Smith

Contact Phone: 515-633-3842

Contact Email: ktsmith@iowaheart.com